Bausch Health Companies (BHC) Other Accumulated Expenses (2010 - 2012)
Bausch Health Companies (BHC) reported Other Accumulated Expenses of $24.5 million for Q4 2012, up 155.71% on a YoY basis from $9.6 million in Q1 2012, and up 155.71% sequentially from $9.6 million in Q4 2011.
Bausch Health Companies (BHC) Other Accumulated Expenses (2010 - 2012) Analysis & Trends
Bausch Health Companies (BHC) has 3 years of Other Accumulated Expenses data on file, last reported at $24.5 million in Q4 2012.
- For the quarter ending Q4 2012, Other Accumulated Expenses rose 155.71% year-over-year to $24.5 million; the trailing twelve-month figure through Dec 2012 stood at $24.5 million (up 155.71% YoY), and the FY2012 full-year result was $24.5 million, up 155.71% from the prior year.
- Other Accumulated Expenses advanced to $24.5 million in Q4 2012, from $9.6 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $59.2 million in Q4 2010 to a low of $9.6 million in Q4 2011.
- A 3-year average of $31.1 million and a median of $24.5 million in 2012 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses slumped 83.8% in 2011 and soared 155.71% in 2012, its largest moves.
- Tracing BHC's Other Accumulated Expenses over 3 years: stood at $59.2 million in 2010, then tumbled by 83.8% to $9.6 million in 2011, then surged by 155.71% to $24.5 million in 2012.
- Business Quant data shows BHC's Other Accumulated Expenses at $24.5 million in Q4 2012, $9.6 million in Q4 2011, and $59.2 million in Q4 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 24.52 Mn |
| Dec 31, 2011 | 9.59 Mn |
| Dec 31, 2010 | 59.22 Mn |